Peptide-peptidase inhibitor conjugates and methods of using same
US8759295B2 · kind B2 · utility
32Cited by
27References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 21, 2010 |
| Grant date | Jun 24, 2014 |
| Priority date | — |
| Expiry date | May 21, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptide-peptidase inhibitor conjugate molecules are disclosed. These conjugate molecules are useful as agents for the treatment and prevention of metabolic and cardiovascular diseases, disorders, and conditions. Such diseases, conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, and other diabetes-related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.